Momenta Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2004 Stock Incentive PlanMomenta Pharmaceuticals Inc • August 16th, 2004 • Biological products, (no disgnostic substances)
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. SECOND AMENDMENT TO THE OCTOBER 31, 2002 LICENSEMomenta Pharmaceuticals Inc • August 16th, 2004 • Biological products, (no disgnostic substances)
This Second Amendment, effective as of the date set forth above the signatures of the parties below, pertains to the Exclusive Patent License Agreement, effective on October 31, 2002, and subsequently amended by a First Amendment dated November 15, 2002 by and between the Massachusetts Institute of Technology ("M.I.T.") and Momenta Pharmaceuticals, Inc. ("COMPANY").
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. FOURTH AMENDMENT TO THE NOVEMBER 1, 2002 LICENSEMomenta Pharmaceuticals Inc • August 16th, 2004 • Biological products, (no disgnostic substances)
This Fourth Amendment, effective as of the date set forth above the signatures of the parties below, pertains to the Amended and Restated Exclusive Patent License Agreement, effective on November 1, 2002, as subsequently amended by a First Amendment on November 15, 2002, a Letter Agreement on September 12, 2003, a Letter Agreement on October 22, 2003, a Second Amendment on November 19, 2003 and a Third Amendment on April 2,2004, by and between the Massachusetts Institute of Technology ("M.I.T.") and Momenta Pharmaceuticals, Inc. ("COMPANY").
